The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

HUMA FINANCIAL STATEMENTS

Humacyte Inc — balance sheet, income statement and cash flow trends

HUMAHumacyte Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-150 M-100 M-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue2.1 M $Gross Profit-14.1 M $ · -667%Operating Income-111.2 M $ · -5241%Pre-tax Income-96.7 M $ · -4561%Net Income to Owners-96.7 M $ · -4561%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.1 M $-73.6%
Gross Profit-14.1 M $—
Operating Income-111.2 M $—
EBITDA-79.7 M $—
Net Income to Owners-96.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets138.1 M
  • Equity31.3 M $23%
  • Current Liabilities14.9 M $11%
  • Long-term Liabilities91.9 M $67%

Key Figures

YoY change
Total Assets138.1 M $-0.5%
Total Liabilities106.8 M $-20.7%
Total Equity31.3 M $+671.5%
Cash & ST Investments79.9 M $+110.1%
Total Debt66.2 M $-21.2%
Net Debt-13.7 M $-129.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M-50 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-97.2 M $Operating-367 K $Investing89.4 M $Financing-8.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-97.2 M $—
Capital Expenditures367 K $-79.5%
Free Cash Flow-97.6 M $—
Dividends Paid0 $—

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on HUMA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.